10 Years Of MedImmune: What Trademark Owners Learned

February 14, 2017, 11:09 AM EST

Law360, New York (February 14, 2017, 11:09 AM EST) -- Last month marked 10 years since the U.S. Supreme Court sided with MedImmune in a royalty dispute with Genentech, transferring the power within a license agreement from the licensor to the licensee. This Law360 Expert Analysis series explores the decision's impact on licensing and litigation.